LOS ANGELES, CALIF. – (July 1, 2026) – The Pancreatic Cancer Action Network (PanCAN), the leading nonprofit organization dedicated to fighting pancreatic cancer, proudly announces new appointments to ...
Contact a PanCAN Patient Services Case Manager for up-to-date information about pancreatic cancer, clinical trial searches, personalized medicine and support resources. All information and services ...
For the most common type of pancreatic cancer, pancreatic ductal adenocarcinoma, more than 90% of tumors are thought to have a KRAS mutation. For decades, these mutations were considered “undruggable, ...
LOS ANGELES, Calif. – (January 13, 2026) – Pancreatic cancer remains the third-leading cause of cancer-related deaths in the United States, behind lung and colorectal cancers. According to the ...
The Pancreatic Cancer Action Network (PanCAN) Leadership Team is a group of dedicated professionals, some of whom have been personally touched by the disease, who bring significant experience and ...
Editor’s note: Each week, our Friday Fix series offers pancreatic cancer patients and caregivers a new topic related to health, diet and nutrition. For today’s post, we highlight healthy foods that ...
Editor’s note: The “Research Spotlight” series is written by Dr. Anna Berkenblit, PanCAN’s Chief Scientific and Medical Officer. Each month, Dr. Berkenblit shares her insights into the latest news and ...
The U.S. Food and Drug Administration (FDA) has approved a wearable medical device used in combination with a standard chemotherapy regimen for the treatment of adult patients with locally advanced ...
FDA Approves New First-line Treatment Option for Metastatic Pancreatic Cancer: What You Need to Know
For the first time in more than a decade, the FDA has approved a new first-line treatment for patients with metastatic pancreatic cancer. After a clinical trial showed a positive survival benefit, the ...
American Cancer Society’s Cancer Facts & Figures 2023, released today, reports that the five-year survival rate for pancreatic cancer is now 12%, an increase of one percentage point from last year.
The types of cancer people are getting and dying from most may be changing in the next 20 years, according to a new study. Published today in JAMA Network Open, PanCAN and our research partners at ...
For the third year in the row, the five-year survival rate for pancreatic cancer has increased one percentage point, according to the American Cancer Society’s Cancer Facts & Figures 2024 Report ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results